UroGen Pharma (URGN) Research & Development (2017 - 2026)
UroGen Pharma (URGN) posted Research & Development of $17.34 million for Q2 2026, down 8.3% from $18.91 million a year earlier but up 11.1% from the prior quarter.
Powered by 
Analysis
UroGen Pharma (URGN) Research & Development (2017 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at UroGen Pharma was $61.26 million, down 5.8% year-over-year; for FY2025, it came in at $67.11 million, up 17.4% from FY2024.
- Annual Research & Development shows a five-year compound annual growth rate of 7.2% (FY2020 to FY2025).
- In prior years, UroGen Pharma's Research & Development was $57.15 million in FY2024 (+25.3%), $45.61 million in FY2023 (-13.8%), $52.91 million in FY2022 (+11.0%) and $47.64 million in FY2021 (+0.7%).
- Quarterly Research & Development has run from a low of $10.23 million in Q3 2023 to a high of $19.87 million in Q1 2025 over five years.
- On a year-over-year basis, Research & Development has declined in each of the last three quarters, with growth averaging 10.4% over the last eight quarters.
- The strongest year-over-year quarter for Research & Development in the past five years was Q2 2024, with growth of 33.0%; the weakest was Q4 2023, with a decline of 21.9%.
- According to Business Quant data, Research & Development for the three prior quarters was $15.6 million (Q1 2026), $14.31 million (Q4 2025) and $14.01 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | UroGen Pharma | 2.00 Bn | 1.50 Bn | 65.88 Mn | 17.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.34 Mn |
| Mar 31, 2026 | 15.60 Mn |
| Dec 31, 2025 | 14.31 Mn |
| Sep 30, 2025 | 14.01 Mn |
| Jun 30, 2025 | 18.91 Mn |
| Mar 31, 2025 | 19.87 Mn |
| Dec 31, 2024 | 14.89 Mn |
| Sep 30, 2024 | 11.36 Mn |
| Jun 30, 2024 | 15.40 Mn |
| Mar 31, 2024 | 15.49 Mn |
| Dec 31, 2023 | 11.30 Mn |
| Sep 30, 2023 | 10.23 Mn |
| Jun 30, 2023 | 11.58 Mn |
| Mar 31, 2023 | 12.50 Mn |
| Dec 31, 2022 | 14.48 Mn |
| Sep 30, 2022 | 13.09 Mn |
| Jun 30, 2022 | 12.64 Mn |
| Mar 31, 2022 | 12.70 Mn |
| Dec 31, 2021 | 13.08 Mn |
| Sep 30, 2021 | 11.92 Mn |
API Access
UroGen Pharma Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=URGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "URGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=URGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();